跳至主要内容
临床试验/NCT05925751
NCT05925751招募中不适用

An Integration of a Computed Tomography/Positron Emission Tomography/Whole Slide Image (CT/PET/WSI) Based Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer: A Multicenter Study

Shanghai Pulmonary Hospital, Shanghai, China3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
3
主要终点
Area under the receiver operating characteristic curve

研究概览

简要总结

The purpose of this study is to evaluate the performance of a CT/PET/ WSI-based deep learning signature for predicting complete pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ranging from 20-75 years;
  • Patients who underwent curative surgery after neoadjuvant chemoimmunotherapy for NSCLC;
  • Obtained written informed consent.

排除标准

  • Missing image data;
  • Pathological N3 disease.

结局指标

主要结局

Area under the receiver operating characteristic curve

时间窗: 2023.5.1-2023.10.31

The area under the receiver operating characteristic curve (ROC) of the deep learning model in predicting complete pathological response (CPR). CPR was defined as no residual tumor in both resected primary tumor and lymph nodes. Patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy will achieve either CPR or non-CPR, which can be confirmed by pathological examination after surgical resection. And the model will output the predictive value (CPR/non-CPR) for each patient receiving neoadjuvant chemoimmunotherapy.

次要结局

  • Sensitivity(2023.5.1-2023.10.31)

研究者

发起方
Shanghai Pulmonary Hospital, Shanghai, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang Chen

Professor

Shanghai Pulmonary Hospital, Shanghai, China

研究点 (3)

Loading locations...

相似试验

Deep Learning Signature for Predicting Complete... | 临床试验